Search Results - "Thunander, M."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden

    Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden by Thunander, M, Petersson, C, Jonzon, K, Fornander, J, Ossiansson, B, Torn, C, Edvardsson, S, Landin-Olsson, M

    Published in Diabetes research and clinical practice (01-11-2008)
    “…Abstract All newly diagnosed diabetes in Kronoberg during 3 years was registered, with blood samples from 1630/1666 (97.8%) adults. Those positive for GADab…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Low Prevalence of Mild Alpha-1-Antitrypsin Deficiency in Hospitalized COVID-19-Patients

    Low Prevalence of Mild Alpha-1-Antitrypsin Deficiency in Hospitalized COVID-19-Patients by Nygren, David, Mölstad, Ulrica, Thulesius, Hans, Hillman, Magnus, Broman, Lars Mikael, Tanash, Hanan, Landin-Olsson, Mona, Rasmussen, Magnus, Thunander, Maria

    Published in International journal of general medicine (01-01-2022)
    “…Alpha-1-antitrypsin (AAT) has been shown to inhibit SARS-CoV-2 cell entry and suggested as a therapeutic agent for COVID-19. Furthermore, epidemiological…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Switching to insulin degludec is a cost-saving therapy for patients with type 1 and type 2 diabetes in the Swedish setting based on real world data

    Switching to insulin degludec is a cost-saving therapy for patients with type 1 and type 2 diabetes in the Swedish setting based on real world data by Jendle, Johan, Thunander, M., Ekman, B., Sjöberg, S., Ericsson, Å., da Rocha Fernandes, J., Mårdby, A.C., Malkin, S.J.P., Hunt, B.

    Published in VALUE IN HEALTH (2019)
    “…Objectives : The Europe-based, prospective, observational ReFLeCT study recently showed that switching to the ultralong-acting basal insulin analogue degludec…”
    Get full text
    Journal Article Conference Proceeding
    Save to List
    Saved in:
  4. 4
    Maternal and perinatal outcomes in all diabetes pregnancies and controls in Kronoberg 2009-2012

    Maternal and perinatal outcomes in all diabetes pregnancies and controls in Kronoberg 2009-2012 by Stogianni, A., Lendahls, Lena, Thunander, M.

    Published in Diabetologia (2017)
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    PDB23 SWITCHING TO INSULIN DEGLUDEC IS A COST-SAVING THERAPY FOR PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES IN THE SWEDISH SETTING BASED ON REAL WORLD DATA

    PDB23 SWITCHING TO INSULIN DEGLUDEC IS A COST-SAVING THERAPY FOR PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES IN THE SWEDISH SETTING BASED ON REAL WORLD DATA by Jendle, J., Thunander, M., Ekman, B., Sjöberg, S., Ericsson, Å., da Rocha Fernandes, J., Mårdby, A.C., Malkin, S.J.P., Hunt, B.

    Published in Value in health (01-11-2019)
    Get full text
    Journal Article
    Save to List
    Saved in:
  6. 6
    Lower Hdl, A Known Marker Of Cardiovascular Risk, Was Associated With Depression In Type 1 Diabetes

    Lower Hdl, A Known Marker Of Cardiovascular Risk, Was Associated With Depression In Type 1 Diabetes by Melin, E., Thulesius, H., Hillman, M., Svensson, R., Landin-Olsson, M., Thunander, M.

    Published in Atherosclerosis (01-08-2019)
    Get full text
    Journal Article
    Save to List
    Saved in:
  7. 7
    Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes in a Swedish setting

    Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes in a Swedish setting by Jendle, JH, Thunander, M, Sjoberg, S, Ekman, B, Mardby, AC, Fernandes, JD, Gundgaard, J, Ericsson, A

    Published in DIABETOLOGIA (2019)
    Get full text
    Conference Proceeding
    Save to List
    Saved in:

Search Tools: